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Background
Methicillin resistant Staphylococcus aureus (MRSA), causes severe and fatal infections 
such as bloodstream infections, infective endocarditis, pneumonia, skin and soft tis-
sue infections and is a global health issue (National Clinical Effectiveness Committee 
2013). Though MRSA can infect all patients, HIV infected patients are more susceptible 
to MRSA due to their compromised immune system (Hidron et al. 2010; Lee et al. 2005; 
Bozzett et al. 2001).
The anterior nares are the most consistent site for MRSA colonization (Otto 2012; 
Wertheim et  al. 2005), yet it can also colonize the axilla, inguinal region, throat, 
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oropharynx, wounds and gastrointestinal tract (Otto 2012; Eveillard et al. 2006; Shahin 
et al. 1999).
MRSA transmission is mainly by direct contact through transient carriage from the 
hands of health care workers, contaminated equipment or with contaminated environ-
mental surfaces (Lowy 1998).
MRSA infections have become increasingly problematic in both health care and com-
munity settings, leading to a greater morbidity, mortality, longer hospital stays, pro-
longed antibiotic administration and increased treatment costs (Government of Western 
Australia Department of Health 2013; Wertheim et al. 2005; Filice et al. 2010; Edem et al. 
2013). Existing literatures show that, HIV patients are six to 18-fold more susceptible to 
MRSA than the general population, and is the main cause of bacteremia and endocar-
ditis in these patients (Popovich et al. 2010; Tumbarello et al. 2002; Burkey et al. 2008; 
Furuno et al. 2011; Franzetti 2006).
There are few studies on MRSA colonization in HIV negative individuals in Ethiopia 
(Shibabaw et al. 2013; Kejela and Bacha 2013). However, there are no data on the preva-
lence and risk factors for MRSA colonization among HIV patients in the country. There-
fore, this study was conducted to fill the existing knowledge gap by determining the 
nasal and throat colonization of MRSA and related risk factors in HIV-infected persons.
Methods
Study design, study period and study area
A cross-sectional study was conducted from September 2014 to February 2015 in three 
selected health centers and one hospital giving HIV care services, namely Kasech Health 
Center, Mekelle Health Center, Semen Health Center and Mekelle Hospital. These health 
facilities were (as the report on September 2014) providing HIV care services for a total 
of 5989 HIV-positive patients.
Sample size
It was determined by taking the prevalence of MRSA from South Africa, which 
was 21  % (Heysell et  al. 2011) using the following formula: n = Z2α/2 P (1− P),
(1.96)2 ∗ 0.21(1− 0.21) = 249.
A proportionate allocation formula (Pandey and Verma 2008) was used to determine 
the sample size from each health facility.
where, k is the number of strata and nj is sample size of the jth stratum
Nj is population size of the jth stratum
n = n1 + n2 + … + nk is the total sample size
N = N1 + N2 + … + Nk is the total population size
The sample size of each health facility is calculated as:
n1 (Mekelle Hospital)  =  160; n2 (Kasech Health center)  =  28; n3 (Semen Heath 





Nj j = 1, 2, 3, k
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Data sources and data collection
A well structured questionnaire in combination with a review of medical records were 
used to collect socio-demographic, risk factors and clinical characteristics of HIV 
positive individuals. Information collected include age, sex, hospitalization in the past 
6  months, hospital visit in the past 12  months, under five children staying in daycare 
centers, homeless (current or past), prison (current or past), surgery in the past 1 year, 
household member’s hospitalization in the past 1 year, presence of percutaneous device 
in the past 1 year, oral antibiotic usage in the past 3 months, current use of Co-trimoxa-
zole, most recent CD4 count.
Specimen collection, transportation, culturing and bacterial isolation
Nasal and throat swabs were collected using sterile cotton swabs pre-moistened with 
sterile normal saline using the standard procedure (D’Avila et al. 2008; Kumar et al. 2013; 
Dhuria et al. 2013). Nasal specimens were obtained by rotating a single swab 2–3 times 
around the inside of the anterior nares, whereas throat specimens were obtained by 
swabbing the posterior pharynx and lateral walls of the pharynx (tonsillar area), with-
out touching the buccal mucosa or tongue. Swabs were then inoculated into the Stuart’s 
Transport media and transported to the Ayder referral hospital medical microbiology 
laboratory within 3–4 h. Swabs were inoculated onto Mannitol Salt Agar (MSA) (Oxiod, 
Hampshire, UK) and incubated at 37 °C aerobically for 24 h. After incubation, yellowish 
colonies from the MSA plate were sub-cultured to Nutrient Agar (Oxiod, Hampshire, 
UK) for further biochemical characterization. Bacterial identification was done based 
on colony morphology, color of the colonies and the tube coagulase test. MRSA isolates 
were identified using Cefoxitin disc by the Kirby-Bauer disk diffusion method (CLSI 
2013).
Antimicrobial susceptibility pattern of MRSA to other antibiotics
The antimicrobial susceptibility testing of MRSA was detected using the modified Kirby-
Bauer disk diffusion method according to the clinical laboratory standard institute 
(CLSI) guidelines (CLSI 2013). The following antimicrobials were used in their respective 
concentration: Ciprofloxacin (5  μg), Trimethoprim-Sulfamethoxazole (1.25/23.75  μg), 
Erythromycin (15  μg), Clindamycin (2  μg), and Amikacin (30  μg) (Hi-Media, India). 
These antimicrobials were selected based on the local usage to treat MRSA and consid-
ering the recommended antimicrobial agents for MRSA infections.
Data processing and analysis
Variables from the demographic and clinical data obtained from the questionnaire and 
laboratory data were cleaned and entered into a computer. Statistical analysis was done 
using SPSS version 20.0 for windows. X2 (Chi square) test was used to determine the 
association of risk factors. P < 0.05, considered as statistically significant and multivariate 
analysis was used to differentiate the independent risk factors for S. aureus colonization.
Quality control
Standard operating procedures (SOPs) were followed during sample collection, trans-
portation, and processing steps. The quality of the culture media and antimicrobial disks 
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were thoroughly checked using standard American Type Culture Collection (ATCC) ref-
erence strain of S. aureus ATCC 25923 obtained from Ethiopian Health and Nutritional 
Research Institute (EHNRI).
Ethical clearance
This study was ethically approved by the Ethical Review Committee (Ref. No-
ERC0453/2014), College of Health Science Mekelle University. Written consent was 
obtained from the study participants or guardians. Patients who were positive for MRSA 
were contacted by the respective doctors for further management. All information of 
participants were kept confidential.
Results
A total of 249 HIV positive individuals attending HIV care service in four health facilities 
were included in the study. The majority of the participants were females 174 (69.9 %). 
The age range of participants were 5–72 years with a mean age of 35 years. The majority 
103 (41.4 %) of the participants were in the age group of 30–39 (Table 1). The overall rate 
of S. aureus and MRSA colonization among the 249 study participants were 81 (32.5 %) 
and 6 (2.4 %) respectively. Distribution of MRSA by nasal, throat and both sites were 3, 2, 
1 respectively and for S. aureus was 41 (50.6 %), 28 (34.6 %) and 12 (14.8 %) respectively.
Analysis of risk factors for S. aureus and MRSA colonization
Variables assessed as risk factors and found with a frequency of less than 10 % of the 
total 249 participants were excluded from the statistical analysis of risk factors for S. 
aureus. These include child aged under 5 years (0), homeless (4), prisoners (2), surgery in 
the past 1 year (3), recent intravenous antibiotic usage (0) and HIV positive individuals 
who have not started antiretroviral therapy (Pre-ART) (7). Two of the homeless, one of 
these previously prisoners, and two of these Pre-ART HIV patients were colonized with 
S. aureus. MRSA was not isolated from the prisoners, those with surgery in the past one 
year, and pre-ART, HIV patients, whereas one person among the homeless participants 
was colonized with MRSA.
Individuals in the age group of 70–79 years were more colonized by S. aureus; how-
ever, there was no statistical significance (p =  0. 59) (Table  1). All the six MRSA was 
isolated from the age groups of 20–49 years (Table 2). S. aureus colonization rate was 
higher among females 62 (35.6 %) as compared to males 19 (25.3 %). However, this was 
not statistically significant (p = 0. 113) (Table 1). All MRSA isolates 6 (3.4 %) were from 
females (Table 2).
Staphylococcus aureus colonization rate was statistically significant in individuals with 
the history of hospitalization, percutaneous device usage within the past 1 year, patients 
with a household member’s hospitalization within past 12  months and patients with 
CD4 count lower than 200 cells/mm3 (p < 0.05) (Table 1). Similarly, MRSA colonization 
was higher in patients with a history of hospitalization (Table  2). Risk factors for the 
colonization of S. aureus with statistical significance in the bivariate analysis were fur-
ther analyzed using multivariate analysis and were found to be significantly associated 
(Table 3).
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Antimicrobial susceptibility pattern of MRSA isolates
Antimicrobial susceptibility testing was performed on the six MRSA isolates against the 
commonly used antibiotics. Accordingly, 16.7, 33.3 and 50 % resistance were observed 
against Ciprofloxacin, Trimethoprim-Sulphamethaxazole, Clindamycin and Erythromy-
cin respectively. Interestingly, all the isolates have shown 100 % sensitivity to Amikacin. 
However, three of the MRSA isolates (50 %) have shown multidrug resistance and all of 
them were isolated from HIV patients in hospital.
Table 1 Analysis of risk factors for Nasal and Throat colonization of S. aureus in HIV posi-
tive individuals attending HIV care service in Northern Ethiopia, September 2014–Febru-
ary 2015
The percent (%) of S. aureus colonization is the proportion of each category
R reference category
Variables Frequency (%) S. aureus colonization
No. (%) OR (95 % CI) P value
Age in years
 1–9R 10 (4.0) 1 (10) NC 0.59
 10–19 19 (7.6) 8 (42.1)
 20–29 35 (14.1) 10 (28.6)
 30–39 103 (41.4) 36 (35.0)
 40–49 55 (22.1) 18 (32.7)
 50–59 17 (6.8) 5 (29.4)
 60–69 7 (2.8) 1 (14.3)
 70–79 3 (1.2) 2 (66.7)
Sex
 FemaleR 174 (69.9) 62 (35.6) 0.613 (0.334–1.123) 0.113
 Male 75 (30.1) 19 (25.3)
Hospitalization in the past 6 months
 NoR 223 (89.6) 60 (26.9) 11.41 (4.12–31.62) 0.000
 Yes 26 (10.4) 21 (80.8)
Hospital visit in the past 12 months
 NoR 61 (24.5) 28 (45.9) 0.463 (0.255–0.839) 0.011
 Yes 188 (75.5) 53 (28.2)
Household member’s hospitalization in the past 1 year
 NoR 224 (90) 60 (26.8) 14.35 (4.732–43.516) 0.000
 Yes 25 (10) 21 (84.0)
Presence of percutaneous device in the past 1 year
 NoR 189 (75.9) 33 (17.5) 18.91 (9.061–39.46) 0.000
 Yes 60 (24.1) 48 (80.0)
Oral antibiotic usage in the past 3 months
 NoR 181 (72.7) 50 (27.6) 2.195 (1.232–3.912) 0.08
 Yes 68 (27.3) 31 (45.6)
Current use of trimethoprim-sulfamethoxazole
 NoR 161 (64.7) 24 (27.3) 1.462 (0.827–2.583) 0.192
 Yes 88 (35.3) 57 (35.4)
Most recent CD4 count
 <200R 37 (14.9) 21 (56.8) 1.00 0.004
 200–500 109 (43.8) 33 (30.3) 0.331 (0.153–0.713) 0.005
 >500 103 (41.4) 27 (26.2) 0.271 (0.123–0.593) 0.001
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Discussion
Our result indicates that the prevalence of S. aureus 81 (32.5 %) and MRSA 6 (2.4 %) was 
lower than similar studies conducted in San Francisco 55.2 % for S. aureus and 27.6 % for 
MRSA (Miller et al. 2003) and India 50.7–81 % for S. aureus and 18.3–42 % for MRSA 
(Dhuria et al. 2013). MRSA prevalence of 2.4 % was similar to the 5.1 % reported from 
Singapore (Kyaw et  al. 2012). However, it was lower than report from other African 
nations with a rate of 20 % in Nigeria (Edem et al. 2013) and 21 % in Kwazu Natal Hospi-
tal South Africa (Heysell et al. 2011).
Table 2 Analysis of risk factors for nasal and throat colonization of MRSA in HIV positive 
individuals attending HIV care service in  Northern Ethiopia, September 2014–February 
2015
The percent (%) of MRSA colonization is the proportion of each category
R reference category
Variables Frequency (%) MRSA colonization
No. (%)
Age in years
 1–9R 10 (4.0) 0 (0)
 10–19 19 (7.6) 0 (0)
 20–29 35 (14.1) 2 (5.7)
 30–39 103 (41.4) 3 (2.9)
 40–49 55 (22.1) 1 (1.8)
 50–59 17 (6.8) 0 (0)
 60–69 7 (2.8) 0 (0)
 70–79 3 (1.2) 0 (0)
Sex
 Female 174 (69.9) 6 (3.4)
 Male 75 (30.1) 0 (0)
Hospitalization in the past 6 months
 No 223 (89.6) 4 (1.8)
 Yes 26 (10.4) 2 (7.7)
Hospital visit in the past 12 months
 No 61 (24.5) 2 (3.3)
 Yes 188 (75.5) 4 (2.1)
Household member hospitalization in the past 1 year
 No 224 (90) 4 (1.8)
 Yes 25 (10) 2 (8.0)
Presence of percutaneous device in the past 1 year
 No 189 (75.9) 2 (1.1)
 Yes 60 (24.1) 4 (6.7)
Oral antibiotic usage in the past 3 months
 No 181 (72.7) 3 (1.7)
 Yes 68 (27.3) 3 (4.4)
Current use of trimethoprim-sulfamethoxazole
 No 161 (64.7) 2 (2.3)
 Yes 88 (35.3) 4 (2.5)
Most recent CD4 count
 <200 37 (14.9) 3 (8.1)
 200–500 109 (43.8) 1 (0.9)
 >500 103 (41.4) 2 (1.9)
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The low prevalence of S. aureus and MRSA colonization in our study might be due to 
the rare visit of these HIV patients to the health facilities, since repeated visits to health 
care centers, or contact with hands of health care workers in HIV infected individuals is 
the major risk factor for the colonization (Hidron et al. 2010; Lowy 1998; Government of 
Western Australia Department of Health 2013).
In our study, the inclusion of throat swabs increased the sensitivity of nasal screening 
of S. aureus and MRSA by 34.6 and 33.3 %, respectively, which was also shown by other 
studies conducted in Bristol, UK (Chow et al. 2012), Singapore (Kyaw et al. 2012) and 
Switzerland (Mertz et al. 2007).
In this study, recent hospitalization was associated with S. aureus colonization. This 
was also showed by other studies conducted in Singapore (Kyaw et  al. 2012; Villacian 
et al. 2004) and TX, USA (Onorato et al. 1999). S. aureus and MRSA colonization rate 
was higher among those who visited hospitals, in the last twelve months; this is in line 
with the result of other study conducted in Singapore (Kyaw et  al. 2012). Presence of 
percutaneous device within the past year was found to have a strong association with S. 
aureus and MRSA colonization. This result was supported by other studies conducted in 
Singapore (Kyaw et al. 2012) and in TX, USA (Onorato et al. 1999).
MRSA colonization was higher in those with Low CD4 count (less than 200/mm3) 
which was also shown by other studies conducted in Singapore (Villacian et  al. 2004) 
and in Dallas, TX, USA (Cenizal et al. 2008). In our study the antimicrobial susceptibility 
pattern of MRSA isolates showed 100 % sensitivity to Amikacin which was similar to the 
study in India (Dhuria et al. 2013).
Conclusions
In this study there was a lower prevalence of MRSA; however, high degree of S. aureus 
colonization among the HIV patients. History of hospitalization, percutaneous device 
usage, patients with a household member’s hospitalization and CD4 count lower than 
200 cells/mm3 were significantly associated with S.aureus colonization. MRSA isolates 
from HIV patients in hospital were more resistant than MRSA isolates obtained from 
health centers. All MRSA isolates were 100 % sensitive to Amikacin.
Table 3 Multivariate analysis of  independent risk factors associated with  S. aureus colo-
nization among HIV positive individuals attending HIV care service in Northern Ethiopia, 
September 2014–February 2015
AOR adjusted odds ratio
Risk factors AOR (95 % CI) P value
Hospitalization in the past 6 months 9.97 (2.69–36.87) 0.001
Hospital visit in the past 12 months 0.31 (0.14–0.697) 0.004
Presence of percutaneous device in the past 1 year 20.695 (8.75–48.96) 0.000
Family member’s hospitalization in the past 1 year 12.97 (3.48–48.30) 0.000
Most recent CD4 count
 <200 0.016
 200–500 0.33 (0.12–0.91) 0.033
 >500 0.22 (0.08–0.06) 0.004
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